Your browser doesn't support javascript.
loading
Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety".
Yamamoto, Hiroyasu; Nobori, Kiyoshi; Matsuda, Yoshimi; Hayashi, Yasuhiro; Hayasaki, Takanori; Akizawa, Tadao.
Afiliação
  • Yamamoto H; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Nobori K; Research and Development Japan, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Matsuda Y; Research and Development Japan, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Hayashi Y; Medical Affairs and Pharmacovigilance, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Hayasaki T; Medical Affairs and Pharmacovigilance, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Akizawa T; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Am J Nephrol ; 52(12): 977-978, 2021.
Article em En | MEDLINE | ID: mdl-34727543
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Prolil-Hidrolase / Anemia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Prolil-Hidrolase / Anemia Idioma: En Ano de publicação: 2021 Tipo de documento: Article